Key steps in the drug development process where our programs help you accelerate:
Form enables exploration of multiple vector designs through computationally-aided rational design. Our in silico tools provide assessments of vector genomic identity, immunogenicity, and manufacturability to optimize and de-risk gene therapy vector sequences.
Form helps ensure you can produce an efficacious, safe drug with high enough yield, and fully characterized.
Form makes it easier to get critical toxicity and safety answers and to be prepared with every bit of data you’ll need for IND submission.
Detailed analysis of the manufactured drug product, including proportion of full AAV viral genomes to non-therapeutic encapsidated species.
Compare the safety, yield and expression of multiple AAV constructs with different vector design elements.
Analyze the potential risks associated with CpG islands and other viral genomic patterns.
Leverage large language models and deep learning to rapidly analyze billions of possible versions of a therapeutic construct.
A comprehensive tech suite built to enable accelerated cell and gene therapy development and computational biology at scale.
An op-ed on bridging the gene therapy “accessibility gap” through manufacturing solutions to extend the reach of transformative treatments to patients worldwide.
In collaboration with independent lab partners, biological study results demonstrate AI can improve manufacturability of gene therapy constructs.
Discover how AI/ML can enhance viral vector manufacturability and address the challenge of construct truncation.
Exclusively recommended multiomics platform for HCLS and academic segments (Google Cloud Premier Partner)
Reference platform integration for Parabricks accelerated genome sequencing
Exclusively recommended bioinformatics solution for gene therapy segment
Exclusive partner in accelerating gene therapy design & development.
"As a Form Bio customer, we are thrilled with the uniquely valuable AI-driven insights they've contributed to our research and development efforts. By working closely with this world class team and cutting edge technology, we can clearly see that applying innovative AI solutions to pre-clinical cell and gene therapy development offers exciting potential for CGT companies' economics, market timing and ability to impact human health."
"Computer-aided design, fabrication, testing analyses and machine learning are key to the future of bioengineering in general and specifically restoration of endangered and extinct genetic diversity for keystone species in vital ecosystems. Form Bio is the software critical to pave the way."
"Form Bio helps Colossal's biology teams save time and maximize our research in ways we didn’t realize were possible. Having access to an incredibly easy-to-use interface coupled with Form’s deep bench of bioinformatics and data science expertise is core to our workflows and how we fulfill our ambitious research objectives."